Patents by Inventor Camilla Fowst

Camilla Fowst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPY
    Publication number: 20110166077
    Abstract: The present invention provides the use of acryloyl distamycin derivatives, in particular ?-bromo- or ?-chloro-acryloyl distamycin derivatives, in combination with radiotherapy, for the treatment of tumors.
    Type: Application
    Filed: October 1, 2004
    Publication date: July 7, 2011
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Maria Geroni, Jennifer Tursi, Camilla Fowst
  • Antitumor therapy comprising distamycin derivatives
    Patent number: 7399748
    Abstract: The present invention relates to an administration schedule comprising the intravenous administration of a ?-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: July 15, 2008
    Assignee: Nerviano Medical Sciences S.r.l.
    Inventors: Camilla Fowst, Franzanne Vreeland, Maria Cristina Rosa Geroni
  • Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
    Publication number: 20060084612
    Abstract: The present invention provides the combined use of acryloyl distamycin derivatives, in particular ?-bromo- and ?-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and a protein kinase (serine/threonine and tyrosine kinases) inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
    Type: Application
    Filed: December 18, 2002
    Publication date: April 20, 2006
    Inventors: Maria Geroni, Camilla Fowst, Paolo Cozzi
  • Method for predicting the sensitivity to chemotherapy
    Patent number: 6969592
    Abstract: The present invention relates to the field of cancer treatment and, more particularly, it relates to a method for predicting the sensitivity towards chemotherapy of a patient, by measuring glutathione (GSH) blood levels of the said patient undergoing chemotherapeutic treatment.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: November 29, 2005
    Assignees: Pharmacia Italia S.p.A., Pharmacia & Upjohn Company LLC
    Inventors: Camilla Fowst, Maria Christina Rosa Geroni, Jennifer Margaret Tursi, Franzanne Vreeland
  • Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
    Publication number: 20050143315
    Abstract: The present invention provides the use of acryloyl distamycin derivatives, in particular ?-bromo- or ?-chloro-acryloyl distamycin derivatives, in combination with radiotherapy, for the treatment of tumors.
    Type: Application
    Filed: October 1, 2004
    Publication date: June 30, 2005
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Maria Geroni, Jennifer Tursi, Camilla Fowst
  • Method for predicting the sensitivity to chemotherapy
    Publication number: 20040175774
    Abstract: Herewith described is a novel method for predicting the sensitivity towards chemotherapy, of a patient in need thereof, which comprises obtaining a blood sample from the patient and detecting the levels of blood glutathione (GSH) as a surrogate marker for glutathione-S-transferase (GST) activity in tumor tissues.
    Type: Application
    Filed: March 2, 2004
    Publication date: September 9, 2004
    Inventors: Camilla Fowst, Geroni Maria Cristina Rosa, Tursi Jennifer Margaret, Vreeland Franzanne
  • Antitumor theraphy comprising distamycin derivatives
    Publication number: 20040006023
    Abstract: The present invention relates to an administration schedule comprising the intravenous administration of a &agr;-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.
    Type: Application
    Filed: June 24, 2003
    Publication date: January 8, 2004
    Inventor: Camilla Fowst
  • Antitumor therapy comprising distamycin derivatives
    Patent number: 6576612
    Abstract: The present invention relates to an administration schedule comprising the intravenous administration of a &agr;-halogen-acryloyl distamycin derivative of formula (I) wherein R is a bromine or chlorine atom; or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: June 10, 2003
    Assignees: Pharmacia Italia S.p.A., Pharmacia & Upjohn Company
    Inventors: Camilla Fowst, Franzanne Vreeland, Maria Cristina Rosa Geroni
  • Method for predicting the sensitivity to chemotherapy
    Publication number: 20030096325
    Abstract: Herewith described is a novel method for predicting the sensitivity towards chemotherapy, of a patient in need thereof, which comprises obtaining a blood sample from the patient and detecting the levels of blood glutathione (GSH) as a surrogate marker for glutathione-S-transferase (GST) activity in tumor tissues.
    Type: Application
    Filed: September 26, 2001
    Publication date: May 22, 2003
    Inventors: Camilla Fowst, Maria Christina Rosa Geroni, Jennifer Margaret Tursi, Franzanne Vreeland